Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to survey the guideline compliance of the cardiologists in the treatment of systolic heart failure in Korea
Major improvement in the medical management of CHF has been achieved in the past decades.
But there is no doubt that prognosis of heart failure patients remains poor. The compliance to the standard treatment can be one of reasons. But very little data concerning this in Korea is available.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| systolic heart failure | EF under 45% |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| guideline adherence | Other | guideline adherence of physician |
|
| Measure | Description | Time Frame |
|---|---|---|
| Mean of modified Guideline Adherence Indicator(mGAI-3) | Modified percentage based on each participant's condition | 1year |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of participants with each class drug prescribed | ARB, BB, ACE-I, aldosterone antagonist | 1year |
| Percentage of participants with daily target dose reached | ARB, BB, ACE-I, aldosterone antagonist |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
admission for systolic heart failure in general hospital
Not provided
| Name | Affiliation | Role |
|---|---|---|
| GSK Clinical Trials | GlaxoSmithKline | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| GSK Investigational Site | Seoul | 135-710 | South Korea |
Not provided
| ID | Term |
|---|---|
| D006333 | Heart Failure |
| D054143 | Heart Failure, Systolic |
| ID | Term |
|---|---|
| D006331 | Heart Diseases |
| D002318 | Cardiovascular Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D019983 | Guideline Adherence |
| D000451 | Mineralocorticoid Receptor Antagonists |
| ID | Term |
|---|---|
| D011787 | Quality of Health Care |
| D006298 | Health Services Administration |
| D017531 | Health Care Evaluation Mechanisms |
| D017530 | Health Care Quality, Access, and Evaluation |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 1year |
| Percentage of all cause mortality | All cause mortality in 1-year after treatment of systolic heart failure | 1year |
| Percentage of All cause hospitalization | All cause hospitalization in 1-year after treatment of systolic heart failure | 1year |
| Mean of mortality or rehospitalization rate according to mGAI-3 | 1year |
| D006727 | Hormone Antagonists |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
| D020164 | Chemical Actions and Uses |
| D062865 | Diuretics, Potassium Sparing |
| D004232 | Diuretics |
| D045283 | Natriuretic Agents |